Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-28

FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Spironolactone from Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)